VANISH Trial

Does early vasopressin use reduce the risk of kidney failure in patients with septic shock compared with norepinephrine?
Continue reading »A compendium of critical appraisals in Intensive Care Medicine research and related specialties
Does early vasopressin use reduce the risk of kidney failure in patients with septic shock compared with norepinephrine?
Continue reading »In patients with severe community-acquired pneumonia and high inflammatory response, does the use of corticosteroids compared to placebo improve outcom
Continue reading »In adults with a head injury, do early corticosteroids compared to placebo reduce death and disability?
Continue reading »Does a prolonged course of intravenous methylprednisolone improve lung function and reduce mortality in patients with unresolving ARDS
Continue reading »In patients with septic shock and relative adrenal deficiency does low dose corticosteroids improve 28 day mortality?
Continue reading »Is short-term (5 days) systemic glucocorticoid treatment in patients with COPD exacerbation as good as conventional (14 days) treatment in clinical outcome and does it decrease the overall exposure to steroids?
Continue reading »In patients in cardiac arrest, does vasopressin + epinephrine during CPR combined with steroid supplementation during and after CPR, improve survival to discharge with a good neurological outcome, in comparison to the use of epinephrine alone?
Continue reading »In adult patients with severe septic shock, does hydrocortisone versus placebo reduce mortality at 28 days?
Continue reading »In patients with early ARDS, does continuous methylprednisolone compared to placebo reduce lung injury scores within 7 days?
Continue reading »